Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $21.7000 (-3.77%) ($21.6600 - $22.7800) on Wed. Jul. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.48% (three month average) | RSI | 50 | Latest Price | $21.7000(-3.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) IBB(51%) ARKG(50%) IWO(47%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -1.74% in a week (0% probabilities). VIXM(-16%) TLT(-13%) UUP(-9%) UNG(-3%) IPO(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.74% (StdDev 3.48%) | Hourly BBV | 0 () | Intraday Trend | -3.9% | | | |
|
Resistance Level | $21.95 | 5 Day Moving Average | $22.62(-4.07%) | 10 Day Moving Average | $22.63(-4.11%) | 20 Day Moving Average | $21.95(-1.14%) | To recent high | -6.3% | To recent low | 43.3% | Market Cap | $1.612b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |